These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9225662)

  • 1. ADHD: the role of the family physician.
    Higgins RW
    Am Fam Physician; 1997 Jul; 56(1):42, 44. PubMed ID: 9225662
    [No Abstract]   [Full Text] [Related]  

  • 2. ADHD guidelines address frequent childhood condition.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Oct; 12(20):5-7. PubMed ID: 12378759
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention deficit hyperactivity disorder in children. The role of the general practitioner.
    Hays RB
    Aust Fam Physician; 1999 Feb; 28(2):101-2. PubMed ID: 10048244
    [No Abstract]   [Full Text] [Related]  

  • 4. Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts.
    Tarver J; Daley D; Sayal K
    Child Care Health Dev; 2014 Nov; 40(6):762-74. PubMed ID: 24725022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.
    Murray DW; Childress A; Giblin J; Williamson D; Armstrong R; Starr HL
    Clin Pediatr (Phila); 2011 Apr; 50(4):308-20. PubMed ID: 21436147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
    So CY; Leung PW; Hung SF
    Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing youth violence: an office-based approach.
    Barkin S
    Pediatr Case Rev; 2003 Jan; 3(1):30-9. PubMed ID: 16222136
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical management of children with hyperactivity. A shift in diagnostic and therapeutic emphasis.
    Hesterly SO
    Postgrad Med; 1986 Apr; 79(5):299-305. PubMed ID: 3960806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit hyperactivity disorder.
    Tucker SM
    J R Soc Med; 1999 May; 92(5):217-9. PubMed ID: 10472254
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].
    Papaseit E; García-Algar O; Simó S; Pichini S; Farré M
    An Pediatr (Barc); 2013 Feb; 78(2):123.e1-10. PubMed ID: 23063334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More attention to ADHD.
    Sakakihara Y
    Dev Med Child Neurol; 2013 Apr; 55(4):296. PubMed ID: 23488944
    [No Abstract]   [Full Text] [Related]  

  • 13. US parents sue psychiatrists for promoting Ritalin.
    Charatan F
    BMJ; 2000 Sep; 321(7263):723. PubMed ID: 10999893
    [No Abstract]   [Full Text] [Related]  

  • 14. Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries.
    Flisher AJ; Sorsdahl K; Hatherill S; Chehil S
    PLoS Med; 2010 Feb; 7(2):e1000235. PubMed ID: 20186271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.
    Rubio B; Hernández S; Verche E; Martín R; González-Pérez P
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism for the efficacy of methylphenidate on attention deficit/hyperactivity disorder and related clinical evidence].
    Okada T
    Seishin Shinkeigaku Zasshi; 2008; 110(10):932-40. PubMed ID: 19278069
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
    Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
    Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 20. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.